Long‐term therapy of multiple basal cell carcinomas: Clinicodermoscopic score for monitoring of intermittent vismodegib treatment

2019 ◽  
Vol 32 (6) ◽  
Author(s):  
Linda Tognetti ◽  
Elisa Cinotti ◽  
Diletta Fiorani ◽  
Caroline Couzan ◽  
Camilla Cavarretta ◽  
...  
1992 ◽  
Vol 84 (5) ◽  
pp. 328-332 ◽  
Author(s):  
J. A. Tangrea ◽  
B. K. Edwards ◽  
P. R. Taylor ◽  
A. M. Hartman ◽  
G. L. Peck ◽  
...  

Dermatology ◽  
2010 ◽  
Vol 221 (4) ◽  
pp. 300-302 ◽  
Author(s):  
B.A. Aigner ◽  
U. Darsow ◽  
M. Grosber ◽  
J. Ring ◽  
S.G. Plötz

1997 ◽  
Vol 17 (03) ◽  
pp. 161-162
Author(s):  
Thomas Hyers

SummaryProblems with unfractionated heparin as an antithrombotic have led to the development of new therapeutic agents. Of these, low molecular weight heparin shows great promise and has led to out-patient therapy of DVT/PE in selected patients. Oral anticoagulants remain the choice for long-term therapy. More cost-effective ways to give oral anticoagulants are needed.


2007 ◽  
Vol 40 (05) ◽  
Author(s):  
M Kungel ◽  
A Engelhardt ◽  
T Spevakné-Göröcs ◽  
M Ebrecht ◽  
C Werner ◽  
...  

1989 ◽  
Vol 51 (2) ◽  
pp. 250-255
Author(s):  
Seiji ARASE ◽  
Hideki NAKANISHI ◽  
Shin HARADA ◽  
Fumio SHIGEMI ◽  
Katsuyuki TAKEDA

Sign in / Sign up

Export Citation Format

Share Document